Regulation of mRNA Translation by Estrogen Receptor in Breast Cancer

Authors

Shahrzad S. Fard, Department of Cell Biology and Anatomy, Graduate School of Biomedical Sciences, New York Medical College, Valhalla, NY, USA.
Marina K. Holz, Department of Cell Biology and Anatomy, Graduate School of Biomedical Sciences, New York Medical College, Valhalla, NY, USA; Department of Biochemistry and Molecular Biology, Graduate School of Biomedical Sciences, New York Medical College, Valhalla, NY, USA. Electronic address: mholz@nymc.edu.

Author Type(s)

Resident/Fellow, Faculty

Journal Title

Steroids

First Page

109316

Document Type

Article

Publication Date

10-6-2023

Department

Cell Biology and Anatomy

Abstract

Breast cancer is one of the leading causes of cancer-related fatalities and the most often diagnosed malignancy in women globally. Dysregulation of sex hormone signaling pathways mediated by the estrogen receptor (ER) in breast cancer is well characterized. Although ER is known to promote cell growth and survival by altering gene transcription, recent research suggests that its effects in cancers are also mediated through dysregulation of protein synthesis. This implies that ER can coordinately affect gene expression through both translational and transcriptional pathways, leading to the development of malignancy. In this review, we will cover the current understanding of how the ER controls mRNA translation in breast cancer and discuss any potential clinical implications of this phenomenon.

Recommended Citation

Fard, S. S., & Holz, M. K. (2023). Regulation of mRNA Translation by Estrogen Receptor in Breast Cancer. Steroids, 200, 109316. https://doi.org/10.1016/j.steroids.2023.109316